Neurobiological biomarkers of response to ketamine
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
As a field, psychiatry is undergoing an exciting paradigm shift toward early identification and intervention that will likely minimize both the burden associated with severe mental illnesses as well as their duration. In this context, the rapid-acting antidepressant ketamine has revolutionized our understanding of antidepressant response and greatly expanded the pharmacologic armamentarium for treatment-resistant depression. Efforts to characterize biomarkers of ketamine response support a growing emphasis on early identification, which would allow clinicians to identify biologically enriched subgroups with treatment-resistant depression who are more likely to benefit from ketamine therapy. This chapter presents a broad overview of a range of translational biomarkers, including those drawn from imaging and electrophysiological studies, sleep and circadian rhythms, and HPA axis/endocrine function as well as metabolic, immune, (epi)genetic, and neurotrophic biomarkers related to ketamine response. Ketamine’s unique, rapid-acting properties may serve as a model to explore a whole new class of novel rapid-acting treatments with the potential to revolutionize drug development and discovery. However, it should be noted that although several of the biomarkers reviewed here provide promising insights into ketamine’s mechanism of action, most studies have focused on acute rather than longer-term antidepressant effects and, at present, none of the biomarkers are ready for clinical use.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stress Effects on Neuronal Structure: Hippocampus, Amygdala, and Prefrontal Cortex
McEwen, B. S., Nasca, C., & Gray, J. D. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2015.171 · Cited by 1,574
Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk
Cohen, S., Janicki-Deverts, D., Doyle, W. J., Miller, G. E., Frank, E., Rabin, B. S., & Turner, R. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118355109 · Cited by 1,419 · cited 1×
“However, prolonged episodes of inflammatory stress promote glucocorticoid resistance (Pariante, 2017), which results in persistent elevations of interleukin-1β (IL-1β) and immune activation (Cohen et al., 2012).”
BackgroundLong-term potentiation depends on release of d-serine from astrocytes
Henneberger, C., Papouin, T., Oliet, S. H. R., & Rusakov, D. A. (2010) · Nature · doi:10.1038/nature08673 · Cited by 1,389
Haroon, E., Raison, C. L., & Miller, A. H. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.205 · Cited by 1,000
Miller, A. H., Haroon, E., Raison, C. L., & Felger, J. C. (2013) · Depression and Anxiety · doi:10.1002/da.22084 · Cited by 892
Meta-analysis of sleep disturbance and suicidal thoughts and behaviors
Pigeon, W. R., Pinquart, M., & Conner, K. (2012) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.11r07586 · Cited by 815
Ketamine: A Review of Clinical Pharmacokinetics and Pharmacodynamics in Anesthesia and Pain Therapy
Peltoniemi, M. A., Hagelberg, N. M., Olkkola, K. T., & Saari, T. I. (2016) · Clinical Pharmacokinetics · doi:10.1007/s40262-016-0383-6 · Cited by 672
Pariante, C. M. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.04.001 · Cited by 382 · cited 1×
“However, prolonged episodes of inflammatory stress promote glucocorticoid resistance (Pariante, 2017), which results in persistent elevations of interleukin-1β (IL-1β) and immune activation (Cohen et al., 2012).”
BackgroundNeutrophil/lymphocyte ratio and platelet/lymphocyte ratio in mood disorders: A meta-analysis
Mazza, M. G., Lucchi, S., Tringali, A. G. M., Rossetti, A., Botti, E. R., & Clerici, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.03.012 · Cited by 326 · cited 1×
“, 2019), a newly recognized hematologic biomarker of peripheral inflammation potentially relevant for depressive disorders (Aydin Sunbul et al., 2016; Mazza et al., 2018).”
BackgroundDo the dissociative side effects of ketamine mediate its antidepressant effects?
Luckenbaugh, D. A., Niciu, M. J., Ionescu, D. F., Nolan, N. M., Richards, E. M., Brutsche, N. E., Guevara, S., & Zarate, C. A. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.02.017 · Cited by 283 · cited 1×
“in psychotic symptoms as assessed by positive symptoms scores on the Brief Psychiatric Rating Scale, and change in diastolic blood pressure, systolic blood pressure, and heart rate at 40min post-infusion were not associated with later antidepressant response to ketamine (Luckenbaugh et al., 2014).”
Self-citationZarate, C. A., Brutsche, N., Laje, G., Luckenbaugh, D. A., Venkata, S. L. V., Ramamoorthy, A., Moaddel, R., & Wainer, I. W. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.004 · Cited by 282
Self-citationSalvadore, G., Cornwell, B. R., Colon-Rosario, V., Coppola, R., Grillon, C., Zarate, C. A., & Manji, H. K. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.014 · Cited by 277 · cited 1×
“One found that, 1 to 3 days before ketamine administration, MDD participants had increased rostral ACC activity in response to fearful faces, while healthy participants’ rostral ACC activity in response to the stimuli decreased (Salvadore et al., 2009); these increases in ACC activity were associated with rapid antide…”
BackgroundSelf-citationDuncan, W. C., Sarasso, S., Ferrarelli, F., Selter, J., Riedner, B. A., Hejazi, N. S., Yuan, P., Brutsche, N., Manji, H. K., Tononi, G., et al. (2013) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145712000545 · Cited by 256
Self-citationHaile, C. N., Murrough, J. W., Iosifescu, D. V., Chang, L. C., Al Jurdi, R. K., Foulkes, A., Iqbal, S., Mahoney, J. J., De La Garza, R., Charney, D. S., et al. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145713001119 · Cited by 253
Ketamine has distinct electrophysiological and behavioral effects in depressed and healthy subjects
Nugent, A. C., Ballard, E. D., Gould, T. D., Park, L. T., Moaddel, R., Brutsche, N. E., & Zarate, C. A. (2019) · Molecular Psychiatry · doi:10.1038/s41380-018-0028-2 · Cited by 250
Self-citationDuman, R. S. (2014) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2014.16.1/rduman · Cited by 249
The effects of ketamine on prefrontal glutamate neurotransmission in healthy and depressed subjects
Abdallah, C. G., De Feyter, H. M., Averill, L. A., Jiang, L., Averill, C. L., Chowdhury, G. M. I., Purohit, P., de Graaf, R. A., Esterlis, I., Juchem, C., et al. (2018) · Neuropsychopharmacology · doi:10.1038/s41386-018-0136-3 · Cited by 229 · cited 2×
“Abdallah and colleagues found that the ratio of carbon-13 (13C) MRS glutamate/glutamine —a putative measure of neurotransmission strength that correlated with Clinician Administered Dissociative States Scale (CADSS) scores—was enriched during ketamine infusion, providing further evidence that ketamine increases glutam…”
BackgroundResultLaje, G., Lally, N., Mathews, D., Brutsche, N., Chemerinski, A., Akula, N., Kelmendi, B., Simen, A., McMahon, F. J., Sanacora, G., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.05.031 · Cited by 213
Self-citationZhang, J.-C., Yao, W., Dong, C., Yang, C., Ren, Q., Ma, M., & Hashimoto, K. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.112 · Cited by 182 · cited 2×
“While the precise mechanisms of ketamine’s anti-inflammatory properties remain unclear, evidence implicates the involvement of the gut microbiome (Getachew et al., 2018; Zhang et al., 2017), NLRP3 inflammasome-mediated upregulation of AMPA receptors (Li et al.”
BackgroundClinical Predictors of Ketamine Response in Treatment-Resistant Major Depression
Niciu, M. J., Luckenbaugh, D. A., Ionescu, D. F., Guevara, S., Machado-Vieira, R., Richards, E. M., Brutsche, N. E., Nolan, N. M., & Zarate, C. A. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.13m08698 · Cited by 165
Self-citationLi, C., Chen, M., Lin, W., Hong, C., Yang, B., Liu, R., Tu, P., & Su, T. (2016) · Human Brain Mapping · doi:10.1002/hbm.23085 · Cited by 152 · cited 1×
“In another [18F]FDG PET imaging study, Li and colleagues found increased glucose metabolism in the PFC post-ketamine, a result that correlated with reduced depressive symptoms within 240min post-ketamine infusion (Li et al., 2016).”
BackgroundAydin Sunbul, E., Sunbul, M., Yanartas, O., Cengiz, F., Bozbay, M., Sari, I., & Gulec, H. (2016) · Psychiatry Investigation · doi:10.4306/pi.2016.13.1.121 · Cited by 145
Milak, M. S., Proper, C. J., Mulhern, S. T., Parter, A. L., Kegeles, L. S., Ogden, R. T., Mao, X., Rodriguez, C. I., Oquendo, M. A., Suckow, R. F., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.83 · Cited by 144 · cited 2×
“Subsequent work by Milak and colleagues found that ketamine affected Glx and gamma aminobutyric acid (GABA) levels in the medial PFC, with significant increases from baseline levels observed in MRS spectra obtained over the course of a 40-min ketamine infusion (Milak et al., 2016); however, these changes were not asso…”
BackgroundTan, S., Wang, Y., Chen, K., Long, Z., & Zou, J. (2017) · Biological & Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00131 · Cited by 142
Murrough, J. W., Burdick, K. E., Levitch, C. F., Perez, A. M., Brallier, J. W., Chang, L. C., Foulkes, A., Charney, D. S., Mathew, S. J., & Iosifescu, D. V. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2014.298 · Cited by 142
The Nucleus Accumbens and Ketamine Treatment in Major Depressive Disorder
Abdallah, C. G., Jackowski, A., Salas, R., Gupta, S., Sato, J. R., Mao, X., Coplan, J. D., Shungu, D. C., & Mathew, S. J. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.49 · Cited by 123
Orozco-Solis, R., Montellier, E., Aguilar-Arnal, L., Sato, S., Vawter, M. P., Bunney, B. G., Bunney, W. E., & Sassone-Corsi, P. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.02.1176 · Cited by 119
Murrough, J. W., Collins, K. A., Fields, J., DeWilde, K. E., Phillips, M. L., Mathew, S. J., Wong, E., Tang, C. Y., Charney, D. S., & Iosifescu, D. V. (2015) · Translational Psychiatry · doi:10.1038/tp.2015.10 · Cited by 109
The role of adipokines in the rapid antidepressant effects of ketamine
Machado-Vieira, R., Gold, P. W., Luckenbaugh, D. A., Ballard, E. D., Richards, E. M., Henter, I. D., De Sousa, R. T., Niciu, M. J., Yuan, P., & Zarate, C. A. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.36 · Cited by 102 · cited 1×
“, 2015); clinical evidence also supports the role of adipokines in humans (Machado-Vieira et al., 2017).”
ResultSelf-citationBenedetti, F., Dallaspezia, S., Fulgosi, M. C., Barbini, B., Colombo, C., & Smeraldi, E. (2007) · Chronobiology International · doi:10.1080/07420520701649455 · Cited by 97 · cited 1×
“Antidepressant response to SD has also been associated with phase advanced activity (Benedetti et al., 2007).”
BackgroundDuncan, W. C., Slonena, E., Hejazi, N. S., Brutsche, N., Yu, K. C., Park, L., Ballard, E. D., & Zarate, C. A. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.03.011 · Cited by 93
Self-citationPark, M., Newman, L. E., Gold, P. W., Luckenbaugh, D. A., Yuan, P., Machado-Vieira, R., & Zarate, C. A. (2017) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.09.025 · Cited by 93 · cited 5×
“…Ma, Dong, & Hashimoto, 2018); however, other studies confirmed the link between treatment-resistant depression and elevated baseline IL-6 levels (Kiraly et al., 2017) but found no association between response to ketamine and shifts in inflammatory markers (Kiraly et al., 2017; Park et al., 2016).”
BackgroundResultSelf-citationMoaddel, R., Luckenbaugh, D. A., Xie, Y., Villaseñor, A., Brutsche, N. E., Machado-Vieira, R., Ramamoorthy, A., Lorenzo, M. P., Garcia, A., Bernier, M., et al. (2015) · Psychopharmacology · doi:10.1007/s00213-014-3669-0 · Cited by 86
Self-citationBaseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder
Duncan, W. C., Selter, J., Brutsche, N., Sarasso, S., & Zarate, C. A. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.05.042 · Cited by 86
Self-citation24-h activity rhythm and sleep in depressed outpatients
Hori, H., Koga, N., Hidese, S., Nagashima, A., Kim, Y., Higuchi, T., & Kunugi, H. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.02.022 · Cited by 78 · cited 1×
“, 2015), lower mesor (Hori et al., 2016), and lower amplitude (Wolff, Putnam, & Post, 1985) with current depressed state.”
BackgroundHippocampal volume and the rapid antidepressant effect of ketamine
Abdallah, C. G., Salas, R., Jackowski, A., Baldwin, P., Sato, J. R., & Mathew, S. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114544776 · Cited by 78
Ketamine Influences CLOCK:BMAL1 Function Leading to Altered Circadian Gene Expression
Bellet, M. M., Vawter, M. P., Bunney, B. G., Bunney, W. E., & Sassone-Corsi, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023982 · Cited by 70
Ketamine normalizes brain activity during emotionally valenced attentional processing in depression
Reed, J. L., Nugent, A. C., Furey, M. L., Szczepanik, J. E., Evans, J. W., & Zarate, C. A. (2018) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.07.006 · Cited by 67
Self-citationVande Voort, J. L., Ballard, E. D., Luckenbaugh, D. A., Bernert, R. A., Richards, E. M., Niciu, M. J., Park, L. T., Machado-Vieira, R., Duncan, W. C., & Zarate, C. A. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10440 · Cited by 65 · cited 1×
“Wakefulness in the 4amhour has been linked to next-day suicidal thoughts (Ballard et al., 2016), and a suicidal ideation response to ketamine was found to be associated with improvements in wakefulness as compared to suicidal ideation non-response (Vande Voort et al., 2017).”
BackgroundSelf-citationWoelfer, M., Li, M., Colic, L., Liebe, T., Di, X., Biswal, B., Murrough, J., Lessmann, V., Brigadski, T., & Walter, M. (2020) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2019.1679391 · Cited by 64 · cited 1×
“Another recent study by Woelfer and colleagues examined the relationship between ketamine response, BDNF levels, and resting-state functional connectivity in 53 healthy volunteers (Woelfer et al., 2019).”
BackgroundChen, M.-H., Li, C.-T., Lin, W.-C., Hong, C.-J., Tu, P.-C., Bai, Y.-M., Cheng, C.-M., & Su, T.-P. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2017.09.008 · Cited by 63
Reed, J. L., Nugent, A. C., Furey, M. L., Szczepanik, J. E., Evans, J. W., & Zarate, C. A. (2019) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2019.01.005 · Cited by 56
Self-citationKraus, C., Mkrtchian, A., Kadriu, B., Nugent, A. C., Zarate, C. A., & Evans, J. W. (2020) · Neuropsychopharmacology · doi:10.1038/s41386-020-0624-0 · Cited by 54 · cited 1×
“Building on this work, Kraus and colleagues used rsfMRI and identical preprocessing strategies to seek to replicate the finding of altered GBC in individuals with treatmentresistant depression; the investigators found significant group differences, with reduced pretreatment GBC in individuals with treatment-resistant…”
MethodSelf-citationBenedetti, F., Calabrese, G., Bernasconi, A., Cadioli, M., Colombo, C., Dallaspezia, S., Falini, A., Radaelli, D., Scotti, G., & Smeraldi, E. (2009) · Psychiatry Research: Neuroimaging · doi:10.1016/j.pscychresns.2008.08.004 · Cited by 53 · cited 1×
“Interestingly, SD and ketamine may share similar biological mechanisms, including altered glutamate/glutamine levels in the ACC followed by NMDA and AMPA receptor signaling coupled with downstream mechanistic target of rapamycin (mTOR) signaling changes (Benedetti et al., 2009; Bunney et al., 2015).”
BackgroundRantamäki, T., & Kohtala, S. (2020) · Pharmacological Reviews · doi:10.1124/pr.119.018697 · Cited by 45
Molecular profile of dissociative drug ketamine in relation to its rapid antidepressant action
Ficek, J., Zygmunt, M., Piechota, M., Hoinkis, D., Rodriguez Parkitna, J., Przewlocki, R., & Korostynski, M. (2016) · BMC Genomics · doi:10.1186/s12864-016-2713-3 · Cited by 42 · cited 2×
“Interestingly, this research revealed similarities in the transcriptional effects of ketamine and those of monoaminergic antidepressants (particularly fluoxetine), suggesting a degree of confluence in the downstream molecular impact of their mechanisms of antidepressant action (Ficek et al., 2016).”
BackgroundMagnetoencephalographic correlates of suicidal ideation in major depression
Gilbert, J. R., Ballard, E. D., Galiano, C. S., Nugent, A. C., & Zarate, C. A. (2020) · Biological Psychiatry: Cognitive Neuroscience and Neuroimaging · doi:10.1016/j.bpsc.2019.11.011 · Cited by 28
Self-citation
Cited by
McIntyre, R. S., Rosenblat, J. D., Nemeroff, C. B., Sanacora, G., Murrough, J. W., Berk, M., Brietzke, E., Dodd, S., Gorwood, P., Ho, R., et al. (2021) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2020.20081251 · Cited by 731
Self-citationKetamine Treatment for Depression: A Review
Yavi, M., Lee, H., Henter, I. D., Park, L. T., & Zarate, C. A. (2022) · Discover Mental Health · doi:10.1007/s44192-022-00012-3 · Cited by 161
“Despite these challenges, studying the mechanistic processes and biomarkers that underlie ketamine’s unique properties has fundamentally changed our understanding of the pathophysiology of mood disorders [87].”
BackgroundSelf-citationNovel Glutamatergic Modulators for the Treatment of Mood Disorders: Current Status
Henter, I. D., Park, L. T., & Zarate, C. A. (2021) · CNS Drugs · doi:10.1007/s40263-021-00816-x · Cited by 142
Self-citationKetamine in neuropsychiatric disorders: an update
Johnston, J. N., Kadriu, B., Kraus, C., Henter, I. D., & Zarate, C. A. (2024) · Neuropsychopharmacology · doi:10.1038/s41386-023-01632-1 · Cited by 108
Self-citationMedeiros, G. C., Gould, T. D., Prueitt, W. L., Nanavati, J., Grunebaum, M. F., Farber, N. B., Singh, B., Selvaraj, S., Machado-Vieira, R., Achtyes, E. D., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01652-1 · Cited by 75
“There is now a significant number of studies on biomarkers of response to ketamine, most of which consist of blood-based assays [31, 42].”
BackgroundSelf-citation
Metadata
- Venue
- Advances in Pharmacology
- Publisher
- Elsevier
- Published
- 2020
- Volume
- 89
- Pages
- 195-235
- ISSN
- 1054-3589 (ISSN-L)
- OpenAlex
- W3035832173
- Cited by
- 36
- References
- 47
- FWCI
- 12.55
- Type
- book chapter
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.